Participants will earn a total of $ 1,100 if they are vaccinated 11 times over a 14-month period.

COVID-19, a new type of corona virus that spread around the world from Wuhan, China, to the point of paralyzing life in the infected countries, has become a major public health problem. Scientists who have extracted the genome of the virus have yet to find a cure for the infection, although they have come up with some important clues.

Kaiser Permanente's research clinic in Seattle, a U.S.-based nonprofit Health Organization, is looking for volunteer subjects for experiments on vaccines to be developed for COVID-19. A total of 45 healthy people in the 18-55 age group who wanted to volunteer drug subjects in a clinical setting would be randomly divided into three groups and each would be given a different dose of the experimental vaccine.

Subjects participating in drug research will earn $ 1,100 at the end of the process

Participants will earn a total of $ 1,100 if they are vaccinated 11 times over a 14-month period. Clinical trials are scheduled to begin next week, but it will be clear in 12 to 18 months whether the tested vaccine is safe or works in humans.

As of now, there are 35 different corona virus vaccines under development worldwide, according to the World Health Organization (who). The results of the mid-and long-term clinical tests will show which of these will be the definitive treatment method. According to data shared by health authorities around the world, COVID-19 has infected more than 113 thousand people globally so far, causing a total of 4,009 people to die.


Articles like this